Accelerated Assessment Success In EU For CSL Behring And Roche
EtranaDez Will Be And Mosunetuzumab Already Is On Fast-Track Review Pathway At EMA
Executive Summary
There have been some recent successes on the accelerated assessment front in the EU but more requests are rejected than granted.